These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6086218

  • 1. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE, Sanders CV, Marier RL.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
    Aldridge KE.
    Diagn Microbiol Infect Dis; 1989 Jun; 12(1):45-50. PubMed ID: 2714072
    [Abstract] [Full Text] [Related]

  • 3. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
    Jones RN, Barry AL, Packer RR.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
    [Abstract] [Full Text] [Related]

  • 4. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA, Henry D, Ngui-Yen J, Castell A, Coderre S.
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
    Canawati HN.
    Diagn Microbiol Infect Dis; 1989 Jun; 12(1):33-7. PubMed ID: 2714070
    [Abstract] [Full Text] [Related]

  • 6. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
    Kobayashi S, Arai S, Hayashi S, Sakaguchi T, Kawana R.
    Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
    Aldridge KE, Weeks LS, Stratton CW, Sanders CV.
    Diagn Microbiol Infect Dis; 1989 May; 12(2):165-70. PubMed ID: 2752714
    [Abstract] [Full Text] [Related]

  • 8. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [Abstract] [Full Text] [Related]

  • 9. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
    Winstanley TG, Spencer RC.
    Drugs Exp Clin Res; 1986 Jun; 12(12):967-71. PubMed ID: 3471432
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
    Wasilauskas BL.
    Diagn Microbiol Infect Dis; 1989 Jun; 12(1):39-43. PubMed ID: 2714071
    [Abstract] [Full Text] [Related]

  • 11. A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus.
    Canawati HN.
    Am J Surg; 1992 Oct; 164(4A Suppl):24S-27S. PubMed ID: 1443357
    [Abstract] [Full Text] [Related]

  • 12. Synergistic activity of cefotaxime and desacetylcefotaxime against the Bacteroides fragilis group.
    Cornick NA, Gorbach SL.
    Diagn Microbiol Infect Dis; 1988 Jun; 10(2):81-4. PubMed ID: 3224498
    [Abstract] [Full Text] [Related]

  • 13. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [Abstract] [Full Text] [Related]

  • 14. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
    Devlin HR, Boskovski L.
    Drugs; 1988 Jun; 35 Suppl 2():45-50. PubMed ID: 3396488
    [Abstract] [Full Text] [Related]

  • 15. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R, Nightingale CH, Tilton R.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [Abstract] [Full Text] [Related]

  • 16. Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
    Jenkins SG, Lewis JW.
    Infection; 1995 Jun; 23(3):154-61. PubMed ID: 7499004
    [Abstract] [Full Text] [Related]

  • 17. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
    Neu HC.
    Rev Infect Dis; 1982 Jun; 4 Suppl():S374-8. PubMed ID: 6294786
    [Abstract] [Full Text] [Related]

  • 18. The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.
    Jones RN.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():39-43. PubMed ID: 6094461
    [Abstract] [Full Text] [Related]

  • 19. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections].
    Pitzus E.
    G Ital Chemioter; 1989 Sep; 36(1-3):57-64. PubMed ID: 2488914
    [Abstract] [Full Text] [Related]

  • 20. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
    Molinari G, Saverino D, Paglia P, Debbia EA, Schito GC.
    J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.